PRESERVING KIDNEY VITALITY: A HOLISTIC FRAMEWORK FOR MANAGING AND PREVENTING DRUG-INDUCED END-STAGE RENAL DISEASE
DOI:
https://doi.org/10.37547/ijasr-03-12-23Keywords:
Renal Health, End-Stage Renal Disease, Drug-Induced NephrotoxicityAbstract
This paper presents a comprehensive framework designed to preserve kidney vitality by effectively managing and preventing drug-induced end-stage renal disease (ESRD). With an increasing incidence of renal complications linked to pharmaceutical agents, a holistic approach is crucial. The proposed framework integrates medical, pharmacological, and lifestyle interventions, emphasizing early detection, risk mitigation, and patient education. By addressing both the underlying causes and proactive preventive measures, this approach aims to minimize the impact of drug-induced ESRD, promoting renal health and well-being.
Downloads
References
Kellum JA, Levin N, Bouman C, Lameire N. Curr Opin Crit Care, 2002;8:509-514.
Mehta RL, Chertow GM. J Am Soc Nephrol, 2003; 14:2178-2187.
Whelton A. Am J Med, 1999; 106:13S-24S.
Han WK, Bailly V, Abichandani R. Kidney Int, 2002; 62:237-244.
Baliga R, Ueda N, Walker PD, Shah SV. Drug Metab Rev, 1999; 31:971-997.
Swan SK. Semin Nephrol, 1997; 17:27-33.
Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Semin Nephrol, 1997; 17:15-26.
Solomon R.. Kidney Int, 1998;53:230-242.
Murphy SW, Barrett BJ, Parfrey PS. J Am Soc Nephrol, 2000; 11:177-182.
Waybill MM, Waybill PN. JV asc Intervent Radiol, 2001; 12:3- 9.
Kintzel PE. Drug Saf, 2001; 24:19-38.
Mizumura Y, Matsumura Y, Hamaguchi T. Jpn J Cancer Res, 2001;92:328-336.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Amish Verma
This work is licensed under a Creative Commons Attribution 4.0 International License.
